Oncology Business Management | Specialty

HER2CLIMB: Implications for Brain Metastases in HER2+ mBC

May 18th 2020

Exciting Results From HER2CLIMB in HER2+ mBC

May 18th 2020

Relapsed/Refractory HER2+ mBC: Evolving Treatment Landscape

May 18th 2020

Cancer Mortality Rate Declined More Steeply in States That Expanded Medicaid Under the Affordable Care Act

May 14th 2020

The cancer mortality rate declined more in states that expanded Medicaid coverage than those that didn’t following the passage of the Affordable Care Act of 2010, a study found.

Video Conference Visits Effective in Reducing Stress, Anxiety in Caregivers for Patients with Cancer

May 14th 2020

The use of video conference technology significantly reduced anxiety and stress among individuals who provide care for an individual with cancer and live more than one hour away from the patient.

Community Oncology Practices Offer Telehealth Tips

May 13th 2020

The need to adapt effectively and provide consistent care to patients with cancer during the public health threat caused by coronavirus disease 2019 has prompted the expanded use of telehealth.

AI System Helps Guide Care for High-Risk Patients in Oncology

May 6th 2020

In an era of value-based care, the ability to triage the needs of patients with cancer who are most likely to experience significant difficulties is becoming a priority for community oncology practices and hospital systems.

COM701 Shows Early Promise as Monotherapy and Combined With Nivolumab in Advanced Solid Tumors

April 30th 2020

COM701, a novel, first-in-class immune checkpoint inhibitor, was found to demonstrate encouraging preliminary antitumor activity and good tolerability when used as either a monotherapy and in combination with nivolumab in a number of heavily pretreated patients with advanced or metastatic solid tumors, according to data from a phase 1 trial.

Value-Based Oncology Models Loop In Patients and Referring Physicians

April 24th 2020

Given the national push for value-based care, oncology practices such as Minnesota Oncology are modifying their treatment models to better coordinate care not only with patients but also with referring physicians.

OncLive News Network: On Location ASCO 2020

April 17th 2020

Join us LIVE at this year's virtual scientific program! OncLive® will broadcast a series of interviews with top thought leaders to share their insights and reactions to data presented during the virtual conference.

Community Oncologist Underscores Importance of Education and Collaboration

April 6th 2020

Derek Thomas, MD, discusses his experience as a community oncologist and some challenges faced in practice.

Real-World Evidence Should Be Part of Clinical Trials in Oncology

March 28th 2020

As cancer treatment shifts from broad chemotherapy to highly personalized therapies, drug development in oncology is also evolving.

Public Health Sector Groans Under Burden of Multiple Epidemics

March 27th 2020

This has been a difficult time for public health policy and regulatory organizations struggling to deal with rapidly changing and unquestionably serious societal health-related issues and concerns. The list of problems these agencies must tackle is growing, and so are the questions about the strategies that should be used to address these threats.

Dr. Chagpar on Limiting the Spread of COVID-19

March 25th 2020

Anees B. Chagpar, MD, MBA, MPH, FACS, FRCS(C), discusses the importance of taking proactive measures to prevent the spread of the novel 2019 coronavirus.

ASCO Meeting Goes Virtual Due to COVID-19

March 24th 2020

Due to COVID-19, the ASCO Annual Meeting will now occur using a virtual format.

UCSF Takes Steps to Stop COVID-19 Spread, Ensure Patient Safety

March 24th 2020

Thomas G. Martin, MD, discusses the risk of COVID-19 to patients with cancer and precautionary measures implemented by the the University of California San Francisco Helen Diller Family Comprehensive Cancer Center.

FDA OKs Launch of Phase III Tocilizumab Trial for COVID-19 Pneumonia

March 23rd 2020

The FDA has approved the initiation of a double-blind, randomized phase III clinical trial of the oncology supportive care drug tocilizumab for use in combination with standard of care for the treatment of hospitalized adult patients with severe COVID-19 pneumonia.

ASCO Speaks Out on COVID-19

March 21st 2020

Experts from ASCO detail the organization's response to the COVID-19 crisis and resources available for its members.

COVID-19 Is "Biggest Medical Issue" of Modern Times, Rugo Says

March 20th 2020

The need to establish preventive procedures that keep pace with the rapid evolution of coronavirus 2019 presents numerous challenges for the oncology field as institutions adapt standard treatment protocols to minimize the risk for virus spread among clinicians and patients alike.

Dr. Brufsky on Case Ascertainment Bias With COVID-19

March 20th 2020

Adam M. Brufsky, MD, PhD, discusses case ascertainment bias regarding the coronavirus 2019.